mattisDr. Steven Mattis, President

Steven Mattis, Ph.D., is President of the Juvenile Bipolar Research foundation. He received his Ph.D. from Columbia University. Dr. Mattis is an internationally known neuropsychologist and recognized as a leading figure in the development of the field of clinical neuropsychology in the United States. He has been on the Board and President of the International Neuropsychological Society; on the Board and President of the Clinical Neuropsychology Division of the American Psychological Association; A Fellow of the American Psychological Association; Founding member of the Board and President of the American Board of Clinical Neuropsychology, the Specialty credentialing agent of the American Board of Professional Psychology; and on the Board and President of the American Board of Professional Psychology. He is currently Clinical Professor of Psychology, Department of Psychiatry, New York Presbyterian Weill Cornell Medical Center and in private practice at Mattis & Luck Center for Neuropsychological Services. Dr. Mattis had been Chief of Neuropsychology in the Department of Neurology, Albert Einstein School of Medicine, Chief of Neuropsychology, Department of Psychiatry, Weill Cornell Medical Center, and Chief Psychologist at Hillside Hospital-Northshore Medical System. He has over 70 articles in peer reviewed journals, multiple chapters in edited books, and is the author of the Dementia Rating Scale. Dr. Mattis has been a co-editor and reviewer for multiple professional journals and served on the Research Review Board for the Human Development and Aging section of the National Institutes of Health.

For the last 10 years, Dr. Mattis has focused his research and clinical interests on the neuropsychology of psychiatric mood disorders. In collaboration with Drs. Papolos and others, he has published several articles delineating a phenotype of juvenile bipolar disorder which has been termed Fear of Harm syndrome.

Sarah Bowman-Deutsch Post DHL (2)(1)Sarah Bowman, Director of Fundraising and Development

Sarah Bowman is Vice President of Investor Relations (IR) at Deutsche Post DHL, a German-listed, Eurostoxx 50 company and global leader in the logistics industry. Sarah is responsible for US investor relations and is a senior member of the award winning DP DHL IR team. In 2015 she was ranked Best IR for a European Company in the US market by IR Magazine.

After nearly 20 years of international, institutional equity sales in positions as Head of Sales, research sales and corporate access management, Sarah transitioned to IR in 2010. With her profound understanding of investor needs, investor relations best practice and cross-cultural communications, she brings a unique perspective to the joint “internal and external” communication role that is IR. She served and continues to serve on the Annual Conference Planning Committee for the National Investor Relations Institute, and is a frequent conference speaker at national and global IR events. Her healthcare related interests include supporting the American Heart Association and American Liver Association for which she fundraises and participates in awareness-related speaking events.

Sarah holds a BA in Philosophy and Economics from Columbia University and is quadralingual.

John Cosentino, Treasurer

John is a founding partner of the Ironwood Manufacturing Fund, a private equity firm specializing in control investments in manufacturing, distribution and service companies. He has been an individual investor leading several investments in privately held companies and is an experienced executive who has held senior management positions with Danaher Corporation, Rau Fastener, Stanley, Black & Decker and several divisions of United Technologies. John presently leads or serves on the boards of Sturm, Ruger & Co., Simonds International Inc., Whitcraft LLC, Habco Industries LLC, and Addaero LLC. He holds an A.B. cum laude in economics from Harvard and an M.B.A. from the Wharton School of the University of Pennsylvania.

Dr. Herbert M. Lachman

Dr. Lachman is a professor in the Department of Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine. He also holds joint appointments in the departments of Medicine, Genetics and Neuroscience. Dr. Lachman became of a member of the JBRF Board of Directors in 2011. He is a co-author of 90 scientific papers, book chapters and reviews. He has also written a book for laymen exploring the role of Darwinian selection in human disease called, “Battle of the Genomes: The Struggle For Survival in a Microbial World.” Dr. Lachman’s primary research interests are the molecular and genetic basis of bipolar disorder and schizophrenia, and the development of patient-specific induced pluripotent stem cell (iPSC) technology to model neuropsychiatric disorders in the laboratory. iPSCs are derived from skin cells and can be turned into human neurons, which can then be studied in animal-free systems. iPSC technology is a very promising tool for developing new drugs for neuropsychiatric disorders. In addition to research, Dr. Lachman sees patients in the Division of Substance Abuse and is very involved in student education at Einstein where he teaches human genetics to first year medical students, and graduate students in the Sue Golding Graduate Division and Clinical Research Training Program. He has received two teaching awards at Einstein. He is also a grand rounds speaker and gives a lecture on the role of genes in criminal behavior at Fordham Law School.

Dr. Lachman is board certified in Internal Medicine and is a member of the American Association for the Advancement of Science and the International Society of Psychiatric Genetics. He is an editor for the Open Psychiatry Journal and the Frontiers in Behavioral Neuroscience and has reviewed papers for some of the top psychiatry and neuroscience journals, including Molecular Psychiatry, Biological Psychiatry, American Journal of Medical Genetics, Human Molecular Genetics and the Archives of General Psychiatry. He has also reviewed grants for 20 NIH study sections. Dr. Lachman lives in Manhattan with his wife and two children.

dr-papolosDr. Demitri Papolos, Director of Research

Demitri Papolos, M.D. is Co-director of the Program in Behavioral Genetics and associate professor of clinical psychiatry at the Albert Einstein College of Medicine in New York City. He has been a recipient of an NIMH Physician/ Scientist Award as well as a NARSAD Independent Investigator Award, and his research findings have been published in the American Journal of Psychiatry, the American Journal of Human Genetics, Molecular Psychiatry, and the Journal of Affective Disorders, among others.

In 2001, Dr. Papolos became the director of research of the Juvenile Bipolar Research Foundation (JBRF) where he established a consortium of clinical and basic researchers from medical centers across the country in order to focus on the root causes of childhood-onset bipolar disorder. These investigators have conducted studies in the fields of phenomenology, neuroimaging, chronobiology, neuropsychological testing, and molecular genetics. Recent work published by Dr. Papolos, and his colleagues may be viewed here.

Because thousands of families have completed the online screening instruments developed by Dr. Papolos, JBRF has been able to assemble the largest clinical database in the world of children with, or at risk for, bipolar disorder. Moreover, these diagnostic instruments are available in multiple languages and are being used by clinics in this country and abroad.

James Bragg

James Bragg is an independent consultant offering consultancy services to corporate investor relations and institutional investment fund managers, having had extensive careers in both financial services and corporate securities law and regulation.

During his career in financial services, James worked as an institutional equity sales professional for several US and international investment banks and devoted a great deal of his time to advising fund management clients on the merits of investments in pharmaceutical, biotech and healthcare services companies. This role required an ongoing relationship with healthcare companies as well as a deep understanding and close following of the drug development and approval process in both the US and Europe. James has maintained a relationship with many of these companies since leaving the financial services industry.

Prior to his equity sales career, James worked as an in-house, corporate securities and compliance lawyer for both Morgan Stanley and PaineWebber, after having worked as an attorney for the US Securities and Exchange Commission in Washington, DC, and as an Assistant District Attorney in the Westchester County District Attorney’s Office.

James holds an AB degree in Government from Franklin & Marshall College and a Juris Doctorate, cum laude, from New York Law School.

James is actively involved in a number of non-profit organizations including the National Exchange Club and as a member of the Vestry of Saint Luke’s Church in Darien. Connecticut.